Given that elevated levels of PAI-1 have been documented as a crucial indicator of endothelial dysfunction in severe COVID-19 patients, we decided to assess its behavior in individuals experiencing post-COVID syndrome. This evidence concerns the gene SERPINE1 and COVID-19.